- Internship - Baylor University Medical Center (2006-2007), General Surgery
- Fellowship - UT MD Anderson Cancer Center (2012-2013), Hematopathology
- Fellowship - UT MD Anderson Cancer Center (2013-2014), Advanced Hematopathology
- Residency - UT Health Science Center at Houston (2008-2012), Anatomic & Clinical Pathology
- Medical School - UT Medical Branch-Galveston (2002-2006)
Jesse Jaso, M.D.
Medical Director, Hematology and Bone Marrow Laboratory - Parkland Memorial Hospital, Dallas, Texas
- Anatomic and Clinical Pathology
Dr. Jaso earned his medical degree at the University of Texas Medical Branch at Galveston. He completed a residency in anatomic and clinical pathology at the UTHealth Houston McGovern Medical School, serving as Chief Resident his final year, and then gained advanced training in hematopathology through a clinical fellowship at MD Anderson Cancer Center.
Certified by the American Board of Pathology in anatomic and clinical pathology, he joined the UT Southwestern faculty in 2016.
Among his other roles, he serves as Program Director of UTSW’s Hematopathology Fellowship, as well as Rotation Director of the Medical Student Selective Rotation in Pathology, the Hematopathology Residency Rotation, and the Medical Student Hematopathology Elective.
Dr. Jaso is a Fellow of the American Society for Clinical Pathology and the College of American Pathologists. He is also a member of the American Association for Cancer Research, the Society for Hematopathology, American Society of Hematology, the National Comprehensive Cancer Network, and the United States and Canadian Academy of Pathology.
He has delivered invited lectures, co-authored the book Hematopathology and Coagulation: Self-Assessment and Board Review, and published numerous academic articles related to his areas of expertise.
When he’s not at work, Dr. Jaso enjoys playing guitar and listening to music; reading biographies, history, politics, and fiction; meditation and spirituality; art and art history; video games; the Dallas Cowboys; and Star Wars.
- American Association for Cancer Research
- American Society for Clinical Pathology
- American Society of Hematology
- College of American Pathologists
- National Comprehensive Cancer Network
- Society for Hematopathology
- United States and Canadian Academy of Pathology
- Vernie A. Stembridge Clinical Pathology Resident Teaching Award 2018, UT Southwestern Medical Center
- Helen Chu Wagner Pathology Residency Award 2012, University of Texas Health Science Center in Houston
- Chief Resident 2011-2012, University of Texas Health Science Center in Houston Anatomic and Clinical Pathology Residency
Hematopathology and Coagulation: Self-Assessment and Board Review
Jaso JM, Tholpady A, Wahed A (2017), New York, Cambridge University Press
- Hematopathology and Coagulation: Self-Assessment and Board Review
Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High Specificity.
Alsuwaidan A, Pirruccello E, Jaso J, Koduru P, Garcia R, Krueger J, Doucet M, Chaudhry R, Fuda F, Chen W Cytometry. Part B, Clinical cytometry 2019 Feb
Post-transplant Lymphoproliferative Disorder Presented in a Form of Primary Effusion Lymphoma with t (8; 14).
Sultana S, Salihi SA, Tandon N, Jaso J, Nguyen ND, Zhang S, Liu J, Annals of clinical and laboratory science 2017 May 47 3 344-348
Fever, Splenomegaly, and Pancytopenia: Histoplasma-Associated Hemophagocytic Lymphohistiocytosis.
Gupta A, Agrawal M, Jaso J Journal of general internal medicine 2017 Mar
Burkitt lymphoma presenting as a mass in the thyroid gland: a clinicopathologic study of 7 cases and review of the literature.
Quesada AE, Liu H, Miranda RN, Golardi N, Billah S, Medeiros LJ, Jaso JM Human pathology 2016 Oct 56 101-8
Phosphorylated STAT3 expression in hematopoietic stem cell transplant-associated large granular lymphocytic leukemia.
Liang CS, Quesada AE, Goswami M, Johnston PK, Brown RE, Jaso JM Bone marrow transplantation 2016 May 51 5 741-3
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Landsburg DJ, Petrich AM, Abramson JS, Sohani AR, Press O, Cassaday R, Chavez JC, Song K, Zelenetz AD, Gandhi M, Shah N, Fenske TS, Jaso J, Medeiros LJ, Yang DT, Nabhan C, Cancer 2016 Feb 122 4 559-64
Acute myeloid leukemia with myelodysplasia-related changes and mutated NPM1
Kojima YA, Golardi N, Jaso JM ASCP Case Reports: Histopathology. 2016 HP 16-3.
Mycosis Fungoides with Follicular Center Helper T-cell Phenotype
Jaso JM, Sargent RL. ASCP Case Reports 2015
Multi-color flow cytometric immunophenotyping for detection of minimal residual disease in AML: past, present and future.
Jaso JM, Wang SA, Jorgensen JL, Lin P Bone marrow transplantation 2014 Sep 49 9 1129-38
Impact of induction regimen and stem cell transplantation on outcomes in patients with double hit lymphoma: a large multicenter retrospective analysis.
Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, Shah KA, Whyman JD, Lansigan F, Hernandez-Ilizaliturri FJ, Lee LX, Barta SK, Melinamani S, Karmali R, Adeimy C, Smith S, Dalal N, Nabhan C, Peace D, Vose J, Evens AM, Shah N, Fenske T, Zelenetz AD, Landsburg DJ, Howlett C, Mato A, Jaglal M, Chavez JC, Tsai JP, Reddy N, Li S, Handler C, Flowers CR, Cohen JB, Blum KA, Song K, Sun HL, Press O, Cassaday R, Jaso J, Medeiros LJ, Sohani AR, Abramson JS Blood 2014 Aug
Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients.
Adrada BE, Miranda RN, Rauch GM, Arribas E, Kanagal-Shamanna R, Clemens MW, Fanale M, Haideri N, Mustafa E, Larrinaga J, Reisman NR, Jaso J, You MJ, Young KH, Medeiros LJ, Yang W Breast cancer research and treatment 2014 Jul
Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems.
Fu B, Jaso JM, Sargent RL, Goswami M, Verstovsek S, Medeiros LJ, Wang SA Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 May 27 5 681-9
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
Wang SA, Hasserjian RP, Fox PS, Rogers HJ, Geyer JT, Chabot-Richards D, Weinzierl E, Hatem J, Jaso J, Kanagal-Shamanna R, Stingo FC, Patel KP, Mehrotra M, Bueso-Ramos C, Young KH, Dinardo CD, Verstovsek S, Tiu RV, Bagg A, Hsi ED, Arber DA, Foucar K, Luthra R, Orazi A, Blood 2014 Apr 123 17 2645-51
B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease.
Jaso JM, Yin CC, Lu VW, Zhao M, Abruzzo LV, You MJ, Yang Y, Luthra R, Medeiros LJ, Lu G Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 Mar 27 3 382-9
Clinicopathologic features of CD5-positive nodal marginal zone lymphoma.
Jaso JM, Yin CC, Wang SA, Miranda RN, Jabcuga CE, Chen L, Medeiros LJ American journal of clinical pathology 2013 Nov 140 5 693-700
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.
Fu B, Ok CY, Goswami M, Xei W, Jaso JM, Muzzafar T, Bueso-Ramos C, Verstovsek S, Garcia-Manero G, Medeiros LJ, Wang SA Annals of hematology 2013 Oct 92 10 1335-43
CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases.
Jaso J, Chen L, Li S, Lin P, Chen W, Miranda RN, Konoplev S, Medeiros LJ, Yin CC Human pathology 2012 Sep 43 9 1436-43
Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors.
Jaso J, Thomas DA, Cunningham K, Jorgensen JL, Kantarjian HM, Medeiros LJ, Wang SA, Cancer 2011 Sep 117 17 4009-17
Adenoid cystic carcinoma.
Jaso J, Malhotra R, Archives of pathology & laboratory medicine 2011 Apr 135 4 511-5
A synoptic reporting system for peripheral blood smear interpretation.
Jaso J, Nguyen A, Nguyen AN, American journal of clinical pathology 2011 Mar 135 3 358-64
Quiz page. CMV colitis presenting as a colonic mass.
Imam SZ, Khan A, Jaso JM, Foringer JR American journal of kidney diseases : the official journal of the National Kidney Foundation 2010 Jan 55 1 A35-7
Upper airway mucus deposition in lung tissue of burn trauma victims.
Cox RA, Mlcak RP, Chinkes DL, Jacob S, Enkhbaatar P, Jaso J, Parish LP, Traber DL, Jeschke MG, Herndon DN, Hawkins HK, Shock (Augusta, Ga.) 2008 Mar 29 3 356-61
- Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High Specificity.
- Next-generation sequencing
- Minimal residual disease
- Flow cytometric immunophenotyping
- Acute myeloid leukemia
- Anatomic and Clinical Pathology